摘要
目的:探究临床药师参与黑曲霉菌肺部感染患者临床抗感染治疗中的作用。方法:临床药师参与1例肺移植术后经第2代测序技术(next-generation sequencing,NGS)检测为黑曲霉菌感染患者的抗感染治疗过程,协助医师调整抗感染治疗方案,并实施药学监护。结果:经两性霉素B治疗后,黑曲霉菌感染患者抗真菌治疗得到有效控制,肺部病灶趋于闭合,病情较为稳定。结论:临床药师参与黑曲霉菌感染患者临床抗真菌治疗,确保了患者用药的安全性及有效性。
Objective:To explore the role of clinical pharmacists participating in the anti-infective medication for patient with Aspergillus Niger pulmonary infection.Methods:The clinical pharmacist participated in the process of antiinfective medication for a patient infected by Aspergillus niger,who was detected by next-generation sequencing,assisting physicians to adjust anti-infective medication plan,and its pharmaceutical care.Results:After amphotericin B treatment,the antifungal medication of Aspergillus Niger infective patient was effectively controlled;the pulmonary lesions tended to close,and the condition was relatively stable.Conclusion:Clinical pharmacists participated in clinical antifungal therapy for patients with Aspergillus Niger to ensure the safety and effectiveness of medication.
作者
陈倩
张稷
杨航
张秀红
CHEN Qian;ZHANG Ji;YANG Hang;ZHANG Xiu-hong(Kunshan No.5 People's Hospital,Kunshan Jiangsu 215300,China;Wuxi People's Hospital Affiliated to Nanjing Medical University,Wuxi Jiangsu 214023,China)
出处
《抗感染药学》
2020年第12期1831-1834,共4页
Anti-infection Pharmacy
基金
江苏省药学会-奥赛康医院药学基金(编号:A201729)
江苏省药学会-天晴医院药学基金(编号:Q2019087)。
关键词
黑曲霉菌
肺部感染
两性霉素B
药学监护
Aspergillus Niger
pulmonary infection
amphotericin B
pharmaceutical care
